254.06
전일 마감가:
$253.71
열려 있는:
$254.81
하루 거래량:
1.26M
Relative Volume:
0.88
시가총액:
$58.83B
수익:
$250.74B
순이익/손실:
$1.55B
주가수익비율:
38.85
EPS:
6.5398
순현금흐름:
$4.39B
1주 성능:
+6.94%
1개월 성능:
+9.25%
6개월 성능:
+19.22%
1년 성능:
+65.76%
카디널 헬스 Stock (CAH) Company Profile
명칭
Cardinal Health Inc
전화
(614) 757-3033
주소
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
254.06 | 58.83B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
MCK
Mckesson Corp
|
1,004.84 | 117.15B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
340.92 | 65.06B | 328.68B | 2.55B | 1.56B | 13.03 |
|
HSIC
Henry Schein Inc
|
86.38 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.35 | 1.16B | 14.85M | -136.07M | 7.25M | -0.4726 |
카디널 헬스 Stock (CAH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-19 | 개시 | RBC Capital Mkts | Outperform |
| 2026-04-28 | 개시 | William Blair | Outperform |
| 2026-01-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-01-06 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-12-13 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Underweight |
| 2023-07-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-03-31 | 개시 | Citigroup | Neutral |
| 2023-02-03 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-05-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-05-18 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-04-12 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2021-08-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-08-05 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-05-10 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-09-25 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-07-20 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-20 | 업그레이드 | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-27 | 다운그레이드 | Argus | Buy → Hold |
| 2019-08-20 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-04-18 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-11-16 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Underperform |
| 2018-01-05 | 개시 | Evercore ISI | In-line |
모두보기
카디널 헬스 주식(CAH)의 최신 뉴스
Cardinal Health stock: Baird's USD 276.00 target leaves Cardinal Health stock 8.09 percent below it - ad-hoc-news.de
Cardinal Health extends CVS deal. Cardinal Health stock costs EUR 226.20 not valid? wait - ad-hoc-news.de
Could Cardinal Health (NYSE:CAH) Be in Focus After Wall Street’s Latest Rotation? - Kalkine Media
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Zacks Investment Research
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cardinal Health Inc (CAH) Shares Surge 3.4% -- What GF Score of 78 Tells Investors - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare
What to Expect From Cardinal Health’s Q1 2027 Earnings Report - Yahoo Finance
What to Expect From Cardinal Health’s Q1 2027 Earnings Report - inkl
Cardinal Health, Inc. (CAH) options chain – Yahoo Finance - Yahoo Finance Singapore
Cardinal Health Could Benefit From RayzeBio's Phase 3 Success, RBC Says - www.marketscreener.com
Here's Why Cardinal Health (CAH) is a Strong Growth Stock - Zacks Investment Research
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026 - GlobeNewswire Inc.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Yahoo Finance
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know - Zacks Investment Research
Cardinal Health stock gains 1.59 percent after CVS pact - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health agrees to extend CVS deal: Cardinal Health stock gains 1.33 percent - AD HOC NEWS
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
CVS renews as Cardinal Health’s largest customer through 2032 - bizjournals.com
Is Cardinal Health Inc (CAH) Overvalued After 3.4% Rally? GF Val - gurufocus.com
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo Finance
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health rises on extended CVS distribution deal - Investing.com
Cardinal Health, McKesson Extend Distribution Pacts With CVS Through 2032 - finance.biggo.com
McKesson and Cardinal Health: CVS Contract Renewal Reaffirms Narrow Moat and Long-Term Growth - Morningstar
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Cardinal Health renews contract with CVS Health - marketscreener.com
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032 - Yahoo Finance
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
Cardinal Health (CAH) Extends CVS Distribution Deal Through 2032, Reaffirms FY2027 EPS Guidance - gurufocus.com
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health - Yahoo Finance
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 - Yahoo! Finance Canada
Cardinal Health rises on extended CVS distribution deal - Yahoo Finance
Cardinal Health: I'm Still Buying After Checking The Numbers (NYSE:CAH) - Seeking Alpha
Total debt per share of Cardinal Health, Inc. – HAN:CLH - TradingView
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend? - TradingView
카디널 헬스 (CAH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
카디널 헬스 주식 (CAH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hollar Jason M. | Chief Executive Officer |
Aug 19 '26 |
Sale |
236.18 |
44,529 |
10,516,660 |
190,603 |
| Mary Scherer | Officer |
Aug 19 '26 |
Proposed Sale |
237.39 |
2,302 |
546,462 |
0 |
| WEITZMAN DEBORAH | CEO, PSS Segment |
Aug 18 '26 |
Sale |
235.45 |
7,354 |
1,731,524 |
77,901 |
| Alt Aaron E | Chief Financial Officer |
Aug 18 '26 |
Sale |
236.34 |
42,000 |
9,926,140 |
20,495 |
| Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 18 '26 |
Sale |
236.19 |
29,436 |
6,952,485 |
33,076 |
| Greene Michelle D. | Chief Information Officer |
Aug 18 '26 |
Sale |
235.72 |
11,650 |
2,746,187 |
10,330 |
| Aaron Alt | Officer |
Aug 18 '26 |
Proposed Sale |
236.34 |
42,000 |
9,926,183 |
0 |
| Michelle Greene | Officer |
Aug 18 '26 |
Proposed Sale |
235.72 |
11,650 |
2,746,148 |
0 |
| Deborah Weitzman | Officer |
Aug 18 '26 |
Proposed Sale |
235.45 |
7,354 |
1,731,534 |
0 |
| Jessica Mayer | Officer |
Aug 18 '26 |
Proposed Sale |
236.19 |
29,436 |
6,952,441 |
0 |
자본화:
|
볼륨(24시간):